We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diffusion-Weighted MRI Technique Cuts Breast Biopsy Requirements

By MedImaging International staff writers
Posted on 18 Oct 2015
Image: A diagnostic DWIBS MRI mammography demonstrating a lesion (Photo courtesy of DKFZ).
Image: A diagnostic DWIBS MRI mammography demonstrating a lesion (Photo courtesy of DKFZ).
An abbreviated magnetic resonance imaging (MRI) protocol could reduce unnecessary breast biopsies by providing additional information on suspicious X-ray screening mammography findings, according to a new study.

Researchers at the German Cancer Research Center (DKFZ; Heidelberg, Germany), University Hospital Heidelberg (Germany), and other institutions conducted a study to evaluate the ability of an abbreviated MRI protocol consisting of maximum intensity projections (MIPs) from diffusion-weighted imaging with background suppression (DWIBS) and unenhanced morphologic sequences to help predict the likelihood of malignancy on suspicious screening X-ray mammograms, as compared with an abbreviated contrast material-enhanced MRI protocol and a full diagnostic breast MRI protocol.

To do so, 50 women (mean age 57.1 years), who gave informed consent and who had suspicious screening mammograms and an indication for biopsy participated in a prospective study from September 2014 to January 2015. Before biopsy, a full diagnostic contrast-enhanced MRI was performed that included DWIBS. Two abbreviated protocols based on MIPs were evaluated; the first showed the shape and appearance of the lesion; the second displayed its biophysiological properties with DWIBS, a technique that works by assessing the diffusion of water molecules through tissue, since areas of restricted diffusion may indicate malignancy.

The results showed that 25 of the 50 participants had a breast carcinoma. DWIBS achieved a comparable accuracy to that of the full diagnostic and the abbreviated contrast-enhanced MRI protocols, yielding an excellent negative predictive value of 92%. Only pure microcalcification related ductal carcinoma in-situ (DCIS) without solid tumor—a very early stage of breast cancer—was not detected by any of the MRI techniques. The study was published early online on September 11, 2015, in Radiology.

“If the preliminary findings are confirmed, this approach could have a high potential to be used as an adjunct in the clarification process of unclear lesions on X-ray mammography in breast cancer screening,” said lead author Sebastian Bickelhaupt, MD, a radiologist at DKFZ. “This might help to reduce the number of invasive biopsies and the related anxiety in women who have suspicious findings at mammography.”

DWIBS MRI holds several advantages; the images can be obtained in less than seven minutes, compared with more than 30 minutes for a full breast MRI protocol; and the mean reading time using the unenhanced DWIBS method is less than 30 seconds thanks to MIPS, a technique that allows lesion assessment by reading one summation image instead of multiple single-slice images. The technique however, is in its early stages, and as such is not intended as a standalone screening modality but as an adjunct to X-ray mammography and tomosynthesis.

Related Links:

German Cancer Research Center
University Hospital Heidelberg


X-Ray Illuminator
X-Ray Viewbox Illuminators
Digital Radiography System
DR-300
X-ray Diagnostic System
FDX Visionary-A
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.